AMANDA WETZEL: Open Payments
NPI 1710489182 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,782 in 137 payments from 31 companies in 2025. Trend: 2023 $2,713 · 2024 $2,182 · 2025 $2,782
Food & beverage: $2,761Education: $21
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 13 | $280 |
| Novo Nordisk Inc | 18 | $258 |
| Xeris Pharmaceuticals, Inc. | 10 | $174 |
| Globus Medical, Inc. | 3 | $173 |
| Amgen Inc. | 9 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $139 |
| Lilly USA, LLC | 9 | $138 |
| Tandem Diabetes Care, Inc. | 7 | $135 |
| Abbott Laboratories | 6 | $120 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $114 |
Products named: Omnipod, Senza, Kerendia, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, GVOKE HYPOPEN, ISTURISA, Rybelsus.
Industry payments across FL — which companies pay providers there.
